IB COMMUNICATIONS PRESS RELEASES

Lakewood, CO – December 17 2024 – Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announced the presentation of three abstracts demonstrating the clinical and cost benefits of using transfusion therapies such as....

Mulhouse, France, December 12, 2024 – CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announced a new memorandum of understanding with Shonan Kamakura General Hospital (SKGH) to transfer technology that will enable GMP manufacturing of....

Wyoming, US, December 11, 2024 – The Blood and Cells Advocacy Roster (BCAR), an industry consortium of blood therapy and cell and gene therapy starting materials stakeholders, launches today to function as a think-tank plus speaker advocacy group. The international organization aims to drive

Barcelona, Spain and Düsseldorf, Germany – 11 December 2024 – Minoryx Therapeutics, a late-stage biotech company focused on the development of therapies for orphan central nervous system (CNS) disorders and Neuraxpharm Group (Neuraxpharm), a leading European.....

Kansas City, MO and Reno, NV, December 11, 2024 – Likarda, a leading biotech company specializing in the development of enabling technologies for the delivery of both cell therapies and large molecule biologics, and VitalTE LifeSciences, today announced....

Ormond Beach, FL, Dec. 9, 2024 – Germfree, a pioneering leader in modular and mobile cleanroom infrastructure, equipment, and services, today announced the launch of Smarthood™, the world’s first software-agnostic, fully integrated intravenous (IV) workflow hardware solution. Smarthood™ is designed to solve persistent....

San Sebastian, Gipuzkoa, Spain, December 4, 2024 - VIVEbiotech, a leading lentiviral vector Contract Development and Manufacturing Organization (CDMO), today announced a growth equity investment from Ampersand Capital Partners....

Lakewood, CO – December 3 2024 – Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, announced funding support for a new clinical trial. Led by sickle cell disease (SCD) experts at France’s Henri Mondor University Hospital....

Ormond Beach, FL, Dec. 3, 2024 – Germfree Laboratories, On Demand Pharmaceuticals (ODP), and North Mississippi Medical Center-Tupelo (NMMC) have teamed up to address the global drug shortage crisis with a groundbreaking point-of-care medicine production solution. The expanding partnership aims to bring agile production of essential....

Lakewood, CO, EUA – 29 October 2024 – Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, is expanding its offerings in Latin America to help bring automated manufacturing to cell and gene therapy companies in Brazil, Colombia and Mexico....

Lakewood, CO, EUA – 29 de octubre de 2024 – Terumo Blood and Cell Technologies (Terumo BCT), una compañía de tecnología médica, está ampliando su oferta en América Latina para ayudar a llevar la fabricación automatizada a las compañías de terapia celular y genética de Brasil, Colombia y México.....

Lakewood, CO – November 21, 2024 – Pain. It haunts patients with sickle cell disease (SCD). They live with the looming threat of acute pain crises that could land them in the hospital — where they can struggle to find relief.

Hangzhou, China – 14 November 2024 – Terumo Blood and Cell Technologies ("Terumo BCT"), today held a localization launch ceremony themed “Unlocking a New Chapter in China, Led by Purpose, Built on Quality” in Hangzhou, Zhejiang Province. The company announced a strategic partnership with Terumo Medical Products (Hangzhou) Co., Ltd.....

Burlington, MA, USA – November 14, 2024 –SEKISUI Diagnostics’ microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGMP capacity expansion at its UK site for clinical-grade drug substance manufacturing.....

Dallas, Texas; November 14, 2024 — Phacilitate, the award-winning team behind Advanced Therapies Week 2025, has released the full agenda for the January event that addresses the evolving landscape of cell and gene therapy, providing an in-depth and provocative look at....

Lakewood, CO – 12 November 2024 – Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announced the launch of its new Global Therapy Innovations business unit, designed to integrate disease expertise based

Rome, Italy November 6th 2024 – In collaboration with the Rwandan government and the Sabin Vaccine Institute, ReiThera has continued to support vaccine development and distribution efforts to curb the ongoing Marburg virus outbreak.

Rome, October 29 2024 - ReiThera has recently completed all manufacturing and quality operations leading to the release of the gene therapy product named AAVB-081, originally developed at TIGEM by the research team of Prof. Alberto Auricchio and now into....

Giessen, Hesse, Germany – October 22, 2024 – Green Elephant Biotech GmbH, the world's first company to develop, manufacture and sell consumables for laboratories made from plant-based plastics, today announced a scaled-down model of its innovative CellScrew®....

Rome, Italy, October 21, 2024 - ReiThera, the GMP viral manufacturer for novel therapies, released the first lot of a non-replicative HSV-1 vector that will support EG 427’s Phase 1b/2a clinical trial of EG110A, an in vivo gene therapy targeting neurogenic detrusor overactivity....

Rome, October 18, 2024 - ReiThera, the Italian-based CDMO offering best-in-class process development and GMP manufacturing services for viral vectors today announces six oral presentations at the European Society of Gene & Cell Therapy 31st Annual Meeting (ESGCT), to be held October 22-25 in Rome.

Lakewood, CO – 17 October 2024 – Terumo Blood and Cell Technologies (Terumo BCT), a global leader in blood management solutions, has launched the Reveos™ Automated Blood Processing System in the United States to help blood centers meet blood and platelet supply needs....

BRISTOL, UK and OTTAWA, CANADA - eXmoor pharma, the full-service cell and gene therapy (CGT) manufacturing partner, and Virica Biotech Inc. (“Virica”), a leading developer of enhancers for scaling of viral vectors as well as cell and gene therapies, announced a new project....

Ormond Beach, FL, October 14, 2024 – Germfree, a pioneering leader in modular and mobile cleanroom infrastructure, equipment and services, today announced the acquisition of Arcoplast, maker of the leading seamless primary barrier cleanroom wall and ceiling system for Life Science applications and more. The acquisition will allow Germfree....

Rome, October 8, 2024 - ReiThera is proud to announce its key role in the fight against the Marburg virus by successfully manufacturing and shipping vaccine doses to Rwanda. In partnership with the Sabin Vaccine Institute, we have provided approximately 700 investigational vaccine doses....

Lakewood, Colorado, 3 October 2024 – Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, and Sanquin Blood Supply Foundation, the Netherlands national blood supply authority, today announced a 10-year agreement to automate....

ReiThera wishes to issue a correction in its release titled 'ReiThera's manufactured Sudan Ebolavirus Vaccine reaches a key milestone with launching of Sabin Vaccine Institute-sponsored Phase 2 Trial in Uganda. The Sabin Vaccine Institute is now referred to as such during the entirety of the release. Previously, this had been incorrectly abbreviated as ’SVI’, which is incorrect.

London, UK and Bristol, UK, 24 September 2024 – Quell Therapeutics Ltd (“Quell” or “the Company”), a world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, and eXmoor pharma (“eXmoor”), the full-service cell and gene therapy (CGT) manufacturing partner, announce a strategic partnership for the manufacture of multiple autologous engineered CAR-Treg cell therapies in Quell’s pipeline targeting autoimmune diseases.

Lakewood, Colorado, U.S., September 23, 2024 - Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company , announced a collaboration with Nova Biomedical (Nova) to enable automated cell culture sensing with Terumo BCT’s Quantum Flex™ Cell Expansion System through integration with Nova’s BioProfile FLEX2 Automated Cell Culture Analyzer. By adding the FLEX2’s on-line automated sampling capabilities, it is possible to automatically sample and analyze a wide array of analytes in Quantum Flex and provide data in near-real time, unlocking more efficient process development and control.

St. Paul, MN – September 18, 2024 – ScaleReadyTM, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReadyTM, today announced that ImmunoScape (a Singapore-U.S. based TCR-T therapy company) has been awarded a G-Rex® Grant.  ImmunoScape’s $250,000 G-Rex® Grant will enable process development and IND enabling studies of their novel WT1-targeted TCR-T cell therapy.

ST. PAUL, MN – September 17, 2024 – ScaleReadyTM, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReadyTM, today announced that it has awarded a $150,000 G-Rex Grant to Verismo Therapeutics, a clinical-stage CAR T company developing the novel KIR-CAR platform technology.  This grant will support Verismo Therapeutics' ongoing efforts to optimize the development and manufacturing of its KIR-CAR platform using the G-Rex.

Miami, Florida, September 17, 2024 – OrganaBio, the cell and gene therapy industry’s hub for tissue sourcing, cell isolation, cryopreservation and clinical sample processing, today announced an expansion of its cell and gene therapy (CGT) starting materials donor base to include patients with over 200 diseases and conditions, including lupus and more than a dozen of the most common autoimmune diseases.

Stem cell charity Anthony Nolan has announced the opening of the Anthony Nolan Cell Collection Centre in Nottingham, UK.  
Founded in 1974, Anthony Nolan created the world’s first stem cell register and has since been a pivotal resource for medical teams seeking unrelated donor transplants for patients, as well as for researchers in the biotech and pharmaceutical industries.

Boca Raton, Florida, September 4, 2024 –  Kosten Digital, a leading developer of custom AI and digital solutions for the healthcare industry, has officially launched in the United States to drive the digital transformation of life sciences and healthcare companies.

Mulhouse, France, August 29, 2024 – CellProthera, a regenerative cell therapy developer specialising in ischemic diseases, announced alignment with regulators on a planned pivotal Phase III trial design for its ProtheraCytes® cell therapy following the completion of its pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration (FDA).

ST. PAUL, Minn., Aug. 27, 2024 - ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that Dr. Steve Feldman, Scientific Director and Site Head of Stanford Medicine's Laboratory for Cell and Gene Medicine (LCGM), has been awarded the inaugural G-Rex® Grant.

Ormond Beach, Fla. and Gaithersburg, Md., August 21, 2024 – GermFree, a pioneering leader in modular cleanroom infrastructure and services, and Caring Cross, a forward-thinking 501(c)(3) nonprofit committed to accelerating the development of advanced medicines and ensuring patient access to transformative therapies, today announced a new partnership to transform access to cell and gene therapies (CGTs).

Bristol, UK, 20 August 2024 – eXmoor pharma, the full-service cell and gene therapy (CGT) manufacturing partner, announced it has received a Manufacturing and Import Authorisation for Investigational Medicinal Products (MIA(IMP)) license from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), authorizing the manufacture of good manufacturing practice (GMP)-grade cell and gene therapy materials for use in clinical trials.

Lakewood, Colorado, August 15, 2024 – Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company , and Charles River Laboratories (Charles River), a global industry-leading drug discovery, preclinical development, manufacturing and testing solutions provider, announced data from a collaborative project demonstrating the versatility of Terumo BCT’s Finia automated fill and finish system in a range of cell and gene therapy (CGT) workflows. The platform was designed to streamline the cooling, aliquoting and packaging steps of cellular product manufacturing, where reproducibility is challenging and cost per failure remains highest.

Miami, Florida, August 13, 2024 – OrganaBio, the cell and gene therapy industry’s hub for tissue sourcing, cell isolation, cryopreservation and clinical sample processing, today announces two new partners that will utilize its current Good Manufacturing Practice (cGMP)-grade cryopreserved (cryo) leukopaks for clinical manufacturing of cell and cell-based therapies. Apheresis material was cryopreserved at OrganaBio’s FDA-registered GMP manufacturing facility, and the cGMP cryo leukopaks are now being shipped to three partners in the United States and abroad with ongoing active studies at pre-clinical and clinical stages.

Mulhouse, France, and Sunnyvale, Ca, US, July 08, 2024 - CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and BioCardia Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announce success from a collaborative Phase II trial of ProtheraCytes for the treatment of acute myocardial infarction (AMI) led by CellProthera, as well as plans to continue the relationship into Phase III.

Mataró, Barcelona, Spain, 11 June, 2024 - Minoryx Therapeutics (“Minoryx”), a late-stage biotech company focused on the development of therapies for orphan central nervous system (CNS) disorders, today announce that results from a compassionate use study of leriglitazone for treatment of progressive cerebral adrenoleukodystrophy (cALD) in adult male patients, published1in the peer-reviewed journal Brain.

Lisboa, Portugal, June 07, 2024 – The MAGIC Consortium is proud to announce the participation of Instituto de Medicina Molecular João Lobo Antunes (iMM) in the MAGIC Project. This expansion is supported through the HORIZON-WIDERA-2023-ACCESS call that aims to widen participation and strengthen the European Research Area.

Miami, Florida, June 05, 2024 – OrganaBio, the cell and gene therapy industry’s hub for tissue sourcing, cell isolation, cryopreservation, contract manufacturing services and clinical sample processing, today announced the expansion of its flagship Cell Processing and Cryopreservation (CPC) Services hub in Irvine, California to support clinical trial services for a large-cap pharmaceutical company. The expansion comes a year after opening the Irvine lab and just months after the October launch of OrganaBio’s CPC Services division.

Kansas City, MO and Franklin, MA, Jun 3, 2024 – Likarda, Inc., leading biotech company specializing in the development of enabling technologies for the delivery of both cell therapies and large molecule biologics, and Cold Chain Technologies, LLC (CCT), a global provider of thermal packaging solutions for the transportation of temperature-sensitive products for the life sciences industry, are pleased to announce a new exclusive licensing agreement to improve the difficult logistics needed for cell therapy manufacturing.

St. Paul, MN, May 29, 2024 – ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced the launch of the G-Rex® Grant Program, a $20 million initiative to propel the advancement of cell and gene-modified cell therapies (CGT).

Lakewood, Colorado, 21 May 2024 – Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, announced the promotion of Mani Venkatesh to Vice President of Digital Transformation (DX), heading the company’s new Digital Transformation Office (DX Office) and joining the Executive Management Committee. Following over two decades in the healthcare industry, Venkatesh joined Terumo BCT in 2020 as Vice President of Global Software Engineering, where he played a critical role in driving efficiencies for customers and helping lead company growth.

Mulhouse, France, May 14, 2024, 11:00am CET – CellProthera, a regenerative cell therapy company developing breakthrough treatments for ischemic diseases, announced positive results from a Phase I/IIb study of its lead ProtheraCytes® in patients following a severe heart attack, positioning the stem cell therapy as a promising option to repair and regenerate heart tissue. The data was presented today by Faiez Zannad, MD, PhD, chairman of the study’s steering committee and emeritus professor of therapeutics at the Université of Lorraine.

Kansas City, USA, April 17, 2024 – Likarda, a leading biotech company specializing in the development of enabling technologies for the delivery of both cell therapies and large molecule biologics, today announces the appointment of Shelly Adams as Chief Commercial Officer. Shelly joins Likarda from Erbi Biosystems, part of Millipore Sigma, where she served as Vice President of Sales......

Mont-Saint-Guibert, Belgium, April 12, 2024 – BioSenic (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, as part of the global restructuring plan announced on 11 April 2024, provides information on (i) the Company's current debt position and the potential impact of the plan on this position .....